Pub Date : 2024-06-28eCollection Date: 2024-12-01DOI: 10.1016/j.atssr.2024.06.011
Kestutis Ručinskas, Lauren S Ranard, Stefano Stella, David Hildick-Smith, Matthew J Price, Vinayak Bapat, Paolo Denti
Purpose: To report the outcomes of the early feasibility study of transapical transcatheter mitral valve replacement (TMVR) with the SATURN System (InnovHeart, Milano, Italy) to treat patients with severe functional mitral regurgitation.
Description: Five high surgical risk patients underwent transapical transcatheter mitral valve replacement with the SATURN System at a single center. One-year follow-up is complete for all patients.
Evaluation: The valve was implanted successfully in all patients without any major adverse events. All patients were alive at the last follow-up. Kansas City Cardiomyopathy Questionnaire improved from a median of 63.5 (interquartile range, 19.6) at baseline to 99.0 (interquartile range, 21.6) at 1 year. Echocardiographic follow-up demonstrates stable valve function, no transvalvular or paravalvular mitral regurgitation, and absence of left ventricular outflow tract obstruction.
Conclusions: At 1 year after transapical SATURN transcatheter mitral valve replacement, all patients are alive with quality of life improvement and favorable device hemodynamics. These initial results are promising and larger scale studies with continued follow-up are required to further elucidate the efficacy and safety of this novel technology.
{"title":"Early Feasibility Study with the SATURN Transapical Mitral Valve Replacement Device.","authors":"Kestutis Ručinskas, Lauren S Ranard, Stefano Stella, David Hildick-Smith, Matthew J Price, Vinayak Bapat, Paolo Denti","doi":"10.1016/j.atssr.2024.06.011","DOIUrl":"10.1016/j.atssr.2024.06.011","url":null,"abstract":"<p><strong>Purpose: </strong>To report the outcomes of the early feasibility study of transapical transcatheter mitral valve replacement (TMVR) with the SATURN System (InnovHeart, Milano, Italy) to treat patients with severe functional mitral regurgitation.</p><p><strong>Description: </strong>Five high surgical risk patients underwent transapical transcatheter mitral valve replacement with the SATURN System at a single center. One-year follow-up is complete for all patients.</p><p><strong>Evaluation: </strong>The valve was implanted successfully in all patients without any major adverse events. All patients were alive at the last follow-up. Kansas City Cardiomyopathy Questionnaire improved from a median of 63.5 (interquartile range, 19.6) at baseline to 99.0 (interquartile range, 21.6) at 1 year. Echocardiographic follow-up demonstrates stable valve function, no transvalvular or paravalvular mitral regurgitation, and absence of left ventricular outflow tract obstruction.</p><p><strong>Conclusions: </strong>At 1 year after transapical SATURN transcatheter mitral valve replacement, all patients are alive with quality of life improvement and favorable device hemodynamics. These initial results are promising and larger scale studies with continued follow-up are required to further elucidate the efficacy and safety of this novel technology.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"765-771"},"PeriodicalIF":0.0,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-28eCollection Date: 2024-12-01DOI: 10.1016/j.atssr.2024.06.015
Kalpana Singh Norbisrath, Sonia Labarinas, Jon Meliones, David McMann, Mehul Patel, Ana Vasquez Choy, Jorge Salazar, Christopher Greenleaf
A patient with known pulmonary atresia and intact ventricular septum and ductal stent presented with low cardiac output and arrythmia. Intraoperatively, the patient was found to have an anomalous left coronary artery arising from the pulmonary artery. After reimplantation of the left coronary artery to the aortic root and placement of a central shunt, the patient progressed well and was discharged home. A high index of suspicion and clear diagnostic visualization of both right and left coronary artery origins are needed to diagnose this highly fatal yet treatable lesion properly.
{"title":"Pulmonary Atresia Intact Ventricular Septum With Anomalous Left Coronary Artery From Pulmonary Artery.","authors":"Kalpana Singh Norbisrath, Sonia Labarinas, Jon Meliones, David McMann, Mehul Patel, Ana Vasquez Choy, Jorge Salazar, Christopher Greenleaf","doi":"10.1016/j.atssr.2024.06.015","DOIUrl":"10.1016/j.atssr.2024.06.015","url":null,"abstract":"<p><p>A patient with known pulmonary atresia and intact ventricular septum and ductal stent presented with low cardiac output and arrythmia. Intraoperatively, the patient was found to have an anomalous left coronary artery arising from the pulmonary artery. After reimplantation of the left coronary artery to the aortic root and placement of a central shunt, the patient progressed well and was discharged home. A high index of suspicion and clear diagnostic visualization of both right and left coronary artery origins are needed to diagnose this highly fatal yet treatable lesion properly.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"884-887"},"PeriodicalIF":0.0,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The prognostic nutritional index has been identified as a predictor of postoperative outcomes in various fields. We investigated the usefulness of the prognostic nutritional index as a risk factor for postoperative complications in secondary spontaneous pneumothorax.
Methods: In this retrospective study, patients who underwent surgery for secondary spontaneous pneumothorax were reviewed. The associations among the prognostic nutritional index, body mass index, and performance status were examined, and risk factors for postoperative complications were investigated in a multivariate analysis. In the subgroup analysis, on the basis of the receiver operating characteristics, we divided patients into high- and low-prognostic nutritional index groups and investigated the utility of the prognostic nutritional index for postoperative complications.
Results: Of 91 patients who underwent surgery for secondary spontaneous pneumothorax, 34 patients with postoperative complications were included. The prognostic nutritional index was significantly positively and negatively correlated with body mass index (P < .001) and performance status (P < .001), respectively. Multivariate analysis revealed that a decreased prognostic nutritional index was an independent risk factor for postoperative complications (P = .0048). In the subgroup analysis, the postoperative outcomes, including the duration of chest tube placement (P = .042), hospital stay (P = .0014), complications (P = .0089), and mortality (P = .044), were significantly worse in the low- than in the high-prognostic nutritional index group.
Conclusions: The prognostic nutritional index may be useful for evaluating the severity of secondary spontaneous pneumothorax in preoperative patients and may be a risk for postoperative complications.
{"title":"Usefulness of Preoperative Prognostic Nutritional Index in Secondary Spontaneous Pneumothorax.","authors":"Toshio Shiotani, Kaoru Kondo, Shinichi Furukawa, Mototsugu Watanabe","doi":"10.1016/j.atssr.2024.06.016","DOIUrl":"10.1016/j.atssr.2024.06.016","url":null,"abstract":"<p><strong>Background: </strong>The prognostic nutritional index has been identified as a predictor of postoperative outcomes in various fields. We investigated the usefulness of the prognostic nutritional index as a risk factor for postoperative complications in secondary spontaneous pneumothorax.</p><p><strong>Methods: </strong>In this retrospective study, patients who underwent surgery for secondary spontaneous pneumothorax were reviewed. The associations among the prognostic nutritional index, body mass index, and performance status were examined, and risk factors for postoperative complications were investigated in a multivariate analysis. In the subgroup analysis, on the basis of the receiver operating characteristics, we divided patients into high- and low-prognostic nutritional index groups and investigated the utility of the prognostic nutritional index for postoperative complications.</p><p><strong>Results: </strong>Of 91 patients who underwent surgery for secondary spontaneous pneumothorax, 34 patients with postoperative complications were included. The prognostic nutritional index was significantly positively and negatively correlated with body mass index (<i>P</i> < .001) and performance status (<i>P</i> < .001), respectively. Multivariate analysis revealed that a decreased prognostic nutritional index was an independent risk factor for postoperative complications (<i>P</i> = .0048). In the subgroup analysis, the postoperative outcomes, including the duration of chest tube placement (<i>P</i> = .042), hospital stay (<i>P</i> = .0014), complications (<i>P</i> = .0089), and mortality (<i>P</i> = .044), were significantly worse in the low- than in the high-prognostic nutritional index group.</p><p><strong>Conclusions: </strong>The prognostic nutritional index may be useful for evaluating the severity of secondary spontaneous pneumothorax in preoperative patients and may be a risk for postoperative complications.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"624-628"},"PeriodicalIF":0.0,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The discussion of Fontan fenestration is difficult because many institutions have different strategies over time. In our institute, we performed a non-fenestrated Fontan procedure for single-ventricular physiology as our definitive strategy.
Methods: Between August 1999 and December 2007, 72 consecutive patients with single-ventricle physiology underwent extracardiac total cavopulmonary connection without fenestration as our definitive strategy. Primary outcomes were Fontan-related events, including death, reoperation, catheter intervention, and postoperative complications such as arrhythmias, protein-losing enteropathy, plastic bronchitis, thrombosis, bleeding, and drainage of pleural effusion after discharge.
Results: The median follow-up duration was 15.7 years (interquartile range, 15.3-18.4). The 1-, 2-, 3-, 5-, 10-, and 15-year occurrence of Fontan-related events was 24%, 43%, 44%, 55%, 67%, and 76%, respectively. The 1-, 2-, 3-, 5-, and 10-year occurrence of venovenous collaterals was 16%, 60%, 65%, 72%, and 81%, respectively. Ventricular end-diastolic pressure was higher in patients with venovenous collaterals (median, 5.0 mm Hg; interquartile range, 4.0-7.0 mm Hg) than in those without (median, 3.5 mm Hg; interquartile range, 3.0-4.25 mm Hg) (P = .01). Multivariable Cox regression analysis showed that higher ventricular end-diastolic pressure and younger age at Fontan completion significantly increased the risk of developing venovenous collaterals, with hazard ratios of 1.22 for each (95% CI, 1.052-1.41; P = .0085 and .016, respectively).
Conclusions: The occurrence rate of Fontan-related events was acceptable with the non-fenestrated Fontan strategy, whereby venovenous collateral development was common. The results suggest that patients with high ventricle end-diastolic pressure and young patients might benefit from fenestration.
背景:丰滩开窗的讨论是困难的,因为随着时间的推移,许多机构有不同的策略。在我们的研究所,我们对单心室生理学进行了无开窗Fontan手术作为我们的最终策略。方法:在1999年8月至2007年12月期间,72例连续的单心室生理患者行不开窗的心外全腔肺连接术。主要结局是fontan相关事件,包括死亡、再手术、导管介入和术后并发症,如心律失常、蛋白质丢失性肠病、可塑性支气管炎、血栓形成、出血和出院后胸腔积液引流。结果:中位随访时间为15.7年(四分位数间距为15.3-18.4)。1年、2年、3年、5年、10年和15年的丰坦相关事件发生率分别为24%、43%、44%、55%、67%和76%。1年、2年、3年、5年和10年静脉侧枝的发生率分别为16%、60%、65%、72%和81%。静脉静脉侧支患者的心室舒张末期压较高(中位数,5.0 mm Hg;四分位数范围,4.0-7.0 mm Hg)比未治疗组(中位数,3.5 mm Hg;四分位数范围为3.0 ~ 4.25 mm Hg) (P = 0.01)。多变量Cox回归分析显示,较高的心室舒张末期压和较年轻的Fontan完成手术年龄显著增加了发生静脉静脉侧枝的风险,两者的风险比为1.22 (95% CI, 1.052-1.41;P = 0.0085和0.016)。结论:非开窗Fontan策略的Fontan相关事件发生率是可以接受的,其中静脉-静脉侧枝发育是常见的。结果表明,高心室舒张末期压患者和年轻患者可能受益于开窗。
{"title":"Long-Term Outcomes of the Non-Fenestrated Strategy for Extracardiac Total Cavopulmonary Connection.","authors":"Daisuke Takeyoshi, Takeshi Konuma, Ai Kojima, Kiyohiro Takigiku, Takamasa Takeuchi, Hiroyuki Kamiya, Yorikazu Harada","doi":"10.1016/j.atssr.2024.06.009","DOIUrl":"10.1016/j.atssr.2024.06.009","url":null,"abstract":"<p><strong>Background: </strong>The discussion of Fontan fenestration is difficult because many institutions have different strategies over time. In our institute, we performed a non-fenestrated Fontan procedure for single-ventricular physiology as our definitive strategy.</p><p><strong>Methods: </strong>Between August 1999 and December 2007, 72 consecutive patients with single-ventricle physiology underwent extracardiac total cavopulmonary connection without fenestration as our definitive strategy. Primary outcomes were Fontan-related events, including death, reoperation, catheter intervention, and postoperative complications such as arrhythmias, protein-losing enteropathy, plastic bronchitis, thrombosis, bleeding, and drainage of pleural effusion after discharge.</p><p><strong>Results: </strong>The median follow-up duration was 15.7 years (interquartile range, 15.3-18.4). The 1-, 2-, 3-, 5-, 10-, and 15-year occurrence of Fontan-related events was 24%, 43%, 44%, 55%, 67%, and 76%, respectively. The 1-, 2-, 3-, 5-, and 10-year occurrence of venovenous collaterals was 16%, 60%, 65%, 72%, and 81%, respectively. Ventricular end-diastolic pressure was higher in patients with venovenous collaterals (median, 5.0 mm Hg; interquartile range, 4.0-7.0 mm Hg) than in those without (median, 3.5 mm Hg; interquartile range, 3.0-4.25 mm Hg) (<i>P</i> = .01). Multivariable Cox regression analysis showed that higher ventricular end-diastolic pressure and younger age at Fontan completion significantly increased the risk of developing venovenous collaterals, with hazard ratios of 1.22 for each (95% CI, 1.052-1.41; <i>P</i> = .0085 and .016, respectively).</p><p><strong>Conclusions: </strong>The occurrence rate of Fontan-related events was acceptable with the non-fenestrated Fontan strategy, whereby venovenous collateral development was common. The results suggest that patients with high ventricle end-diastolic pressure and young patients might benefit from fenestration.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"820-824"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-27eCollection Date: 2024-12-01DOI: 10.1016/j.atssr.2024.06.014
Shaivy Malik, Charanjeet Ahluwalia, Sana Ahuja
Synovial sarcoma is a rare malignant mesenchymal neoplasm primarily affecting adolescents and young adults, and it typically arises from deep soft tissues near large joints. Although commonly found in extremities, it can occur in various anatomic locations. We present a rare case of a 29-year-old man with primary pulmonary synovial sarcoma manifesting as a cystic mass masquerading as a lung hydatid cyst. Histopathologic examination, immunohistochemistry, and molecular analysis aided in accurate diagnosis. This case underscores the importance of considering synovial sarcoma in the differential diagnosis of pulmonary cysts and highlights the crucial role of pathologic examination in guiding treatment decisions.
{"title":"Primary Pulmonary Synovial Sarcoma With Extensive Myxoid Change Masquerading as a Lung Hydatid Cyst.","authors":"Shaivy Malik, Charanjeet Ahluwalia, Sana Ahuja","doi":"10.1016/j.atssr.2024.06.014","DOIUrl":"10.1016/j.atssr.2024.06.014","url":null,"abstract":"<p><p>Synovial sarcoma is a rare malignant mesenchymal neoplasm primarily affecting adolescents and young adults, and it typically arises from deep soft tissues near large joints. Although commonly found in extremities, it can occur in various anatomic locations. We present a rare case of a 29-year-old man with primary pulmonary synovial sarcoma manifesting as a cystic mass masquerading as a lung hydatid cyst. Histopathologic examination, immunohistochemistry, and molecular analysis aided in accurate diagnosis. This case underscores the importance of considering synovial sarcoma in the differential diagnosis of pulmonary cysts and highlights the crucial role of pathologic examination in guiding treatment decisions.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"669-671"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-25eCollection Date: 2024-12-01DOI: 10.1016/j.atssr.2024.06.006
Daniel Kyrillos Ragheb, Sigrid Johannesen, Erin Gillaspie
A 44-year-old man with a history of facioscapulohumeral muscular dystrophy and pectus excavatum presented with multiyear history of progressive, severe respiratory dysfunction, pain, recurrent respiratory infection, and chest wall deformity. With bioprosthetic engineers, the surgical team customized a 3-dimensional printed model of a sternal implant interacting with the patient's anatomy. After approval from the Food and Drug Administration, the customized sternal plates were created and implanted in a sternal reconstruction operation. We report on the successful implantation of a customized sternal plate in the treatment of a patient with refractory pectus excavatum in the context of facioscapulohumeral muscular dystrophy.
{"title":"Sternal Reconstruction for Refractory Pectus Excavatum From Facioscapulohumeral Muscular Dystrophy.","authors":"Daniel Kyrillos Ragheb, Sigrid Johannesen, Erin Gillaspie","doi":"10.1016/j.atssr.2024.06.006","DOIUrl":"10.1016/j.atssr.2024.06.006","url":null,"abstract":"<p><p>A 44-year-old man with a history of facioscapulohumeral muscular dystrophy and pectus excavatum presented with multiyear history of progressive, severe respiratory dysfunction, pain, recurrent respiratory infection, and chest wall deformity. With bioprosthetic engineers, the surgical team customized a 3-dimensional printed model of a sternal implant interacting with the patient's anatomy. After approval from the Food and Drug Administration, the customized sternal plates were created and implanted in a sternal reconstruction operation. We report on the successful implantation of a customized sternal plate in the treatment of a patient with refractory pectus excavatum in the context of facioscapulohumeral muscular dystrophy.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"685-687"},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-25eCollection Date: 2024-12-01DOI: 10.1016/j.atssr.2024.06.005
Marvi Tariq, Benjamin Wei
Pulmonary mucormycosis is a rapidly progressive and highly morbid disease commonly found in immunosuppressed patients. Rapid diagnosis and treatment are essential, with thoracotomy and video-assisted thoracoscopic surgery techniques previously described for surgical resection of infected lobes. Here we present the case of a patient with acute myeloid leukemia and nonresolving Mucor pneumonia treated with robotic left upper lobectomy. The patient had an uneventful postoperative course and significant clinical improvement, thereby demonstrating the feasibility of the robotic approach in treating patients with invasive fungal infections of the lung.
{"title":"To Cut (Minimally Invasively) Is to Cure: Robotic Lobectomy for Pulmonary Mucormycosis.","authors":"Marvi Tariq, Benjamin Wei","doi":"10.1016/j.atssr.2024.06.005","DOIUrl":"10.1016/j.atssr.2024.06.005","url":null,"abstract":"<p><p>Pulmonary mucormycosis is a rapidly progressive and highly morbid disease commonly found in immunosuppressed patients. Rapid diagnosis and treatment are essential, with thoracotomy and video-assisted thoracoscopic surgery techniques previously described for surgical resection of infected lobes. Here we present the case of a patient with acute myeloid leukemia and nonresolving <i>Mucor</i> pneumonia treated with robotic left upper lobectomy. The patient had an uneventful postoperative course and significant clinical improvement, thereby demonstrating the feasibility of the robotic approach in treating patients with invasive fungal infections of the lung.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"629-632"},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708524/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-25eCollection Date: 2024-12-01DOI: 10.1016/j.atssr.2024.06.008
Tanisha Rajah, David Blitzer, Hannah Copeland, Hiroo Takayama
Background: Cardiothoracic surgery (CTS) is one of the least diverse surgical specialties in both gender and race. Aside from the inherent benefits of a diverse working environment, mitigating this diversity gap improves patient care. Mentorship is important for creating a diverse, nurturing environment for trainees. This review appraises the impact of formal mentorship for trainees and specifically assesses its significance for underrepresented groups in CTS.
Methods: A literature search was performed using keywords relating to CTS, mentorship, and underrepresented groups. Principal findings were extracted and synthesized; supporting literature discussing mentorship in other surgical specialties was also included.
Results: Mentorship is desired by CTS residents. Its benefits include aiding the matching process, decreasing stress, and increasing academic productivity. Mentorship programs can be used to increase the recruitment and retention of women and others underrepresented in medicine.
Conclusions: Mentorship is a valuable tool for which implementation must be prioritized in CTS; this requires more education on mentorship for trainees. Institutions should be using mentorship programs to diversify trainees in CTS with the objective being equality.
{"title":"Facilitating a More Diverse Workforce: The Value of Mentorship in Cardiothoracic Surgery.","authors":"Tanisha Rajah, David Blitzer, Hannah Copeland, Hiroo Takayama","doi":"10.1016/j.atssr.2024.06.008","DOIUrl":"10.1016/j.atssr.2024.06.008","url":null,"abstract":"<p><strong>Background: </strong>Cardiothoracic surgery (CTS) is one of the least diverse surgical specialties in both gender and race. Aside from the inherent benefits of a diverse working environment, mitigating this diversity gap improves patient care. Mentorship is important for creating a diverse, nurturing environment for trainees. This review appraises the impact of formal mentorship for trainees and specifically assesses its significance for underrepresented groups in CTS.</p><p><strong>Methods: </strong>A literature search was performed using keywords relating to CTS, mentorship, and underrepresented groups. Principal findings were extracted and synthesized; supporting literature discussing mentorship in other surgical specialties was also included.</p><p><strong>Results: </strong>Mentorship is desired by CTS residents. Its benefits include aiding the matching process, decreasing stress, and increasing academic productivity. Mentorship programs can be used to increase the recruitment and retention of women and others underrepresented in medicine.</p><p><strong>Conclusions: </strong>Mentorship is a valuable tool for which implementation must be prioritized in CTS; this requires more education on mentorship for trainees. Institutions should be using mentorship programs to diversify trainees in CTS with the objective being equality.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"888-894"},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-06-25eCollection Date: 2024-12-01DOI: 10.1016/j.atssr.2024.06.007
Mohamad K Abou Chaar, Giovanna Grigsby-Rocca, Ming Huang, Shanda H Blackmon
Background: The objective of this study was to compare generative artificial intelligence-initiated care pathways, using ChatGPT, with expert-guided consensus-initiated care pathways from AskMayoExpert (AME) for symptom management of esophageal cancer patients after esophagectomy.
Methods: A formal protocol for development of 9 AME care pathways was followed for specific patient-identified domains after esophagectomy for esophageal cancer. Domain scores were measured and assessed through the Upper Digestive Disease tool. These care pathways were developed by experts validated by a consensus-driven methodology. ChatGPT was used to answer specific questions similar to the AME care pathway on April 9, 2023, and March 28, 2024. To compare outcomes, answers were recorded, and algorithms were compared with a survey tool composed of 5 questions.
Results: Both modalities were able to provide a clear definition with multidirectional management options for all 9 domains: dysphagia, generalized dumping, gastrointestinal dumping, pain, regurgitation, heartburn, nausea, physical health, and mental health. When provided with a simple prompt, ChatGPT 3.5 failed to provide a comprehensive stepwise approach for providers, any testing recommendations, or any form of triage process. However, ChatGPT 4.0 provided plans, similar to AME care pathways, when a sophisticated prompt was used.
Conclusions: Generative artificial intelligence-initiated care pathways can be used by physicians as a supplementary tool to guide provider management of patients with complex symptoms after esophagectomy. This technology will continue to advance but is currently insufficient to solely guide clinical management of complex patients with severe symptoms.
{"title":"ChatGPT vs Expert-Guided Care Pathways for Postesophagectomy Symptom Management.","authors":"Mohamad K Abou Chaar, Giovanna Grigsby-Rocca, Ming Huang, Shanda H Blackmon","doi":"10.1016/j.atssr.2024.06.007","DOIUrl":"10.1016/j.atssr.2024.06.007","url":null,"abstract":"<p><strong>Background: </strong>The objective of this study was to compare generative artificial intelligence-initiated care pathways, using ChatGPT, with expert-guided consensus-initiated care pathways from AskMayoExpert (AME) for symptom management of esophageal cancer patients after esophagectomy.</p><p><strong>Methods: </strong>A formal protocol for development of 9 AME care pathways was followed for specific patient-identified domains after esophagectomy for esophageal cancer. Domain scores were measured and assessed through the Upper Digestive Disease tool. These care pathways were developed by experts validated by a consensus-driven methodology. ChatGPT was used to answer specific questions similar to the AME care pathway on April 9, 2023, and March 28, 2024. To compare outcomes, answers were recorded, and algorithms were compared with a survey tool composed of 5 questions.</p><p><strong>Results: </strong>Both modalities were able to provide a clear definition with multidirectional management options for all 9 domains: dysphagia, generalized dumping, gastrointestinal dumping, pain, regurgitation, heartburn, nausea, physical health, and mental health. When provided with a simple prompt, ChatGPT 3.5 failed to provide a comprehensive stepwise approach for providers, any testing recommendations, or any form of triage process. However, ChatGPT 4.0 provided plans, similar to AME care pathways, when a sophisticated prompt was used.</p><p><strong>Conclusions: </strong>Generative artificial intelligence-initiated care pathways can be used by physicians as a supplementary tool to guide provider management of patients with complex symptoms after esophagectomy. This technology will continue to advance but is currently insufficient to solely guide clinical management of complex patients with severe symptoms.</p>","PeriodicalId":72234,"journal":{"name":"Annals of thoracic surgery short reports","volume":"2 4","pages":"674-679"},"PeriodicalIF":0.0,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}